This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

There are many possible explanations for that, including side effects and the drug’s cost. According to a KFF analysis, the list price for GLP-1 drugs can range between $936 and $1,349 before ...

Safety Concerns and Liability Issues for GLP-1 Drugs GLP-1 medications ... For instance, at the start of 2024, the US list prices of Ozempic (Novo Nordisk) and Mounjaro (Eli Lilly) increased ...

The GLP-1 drugs – I just realised I don’t actually ... put it on the medical shortage list in America. What that means, interestingly enough for very logical reasons, if you are on the list ...

Wegovy (semaglutide) has a list price of $1,349.02 for a four-week ... and a ploy to drive sales of “knockoff” GLP-1 drugs. “Obesity is a chronic disease, not a character flaw—we continue ...

The full list of key “news-flow” events in 2025 ... That asset could be one of the three GLP-1 agonist drugs Roche is guiding through clinical studies, that it acquired via is $2.7bn ...